We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: Four Drug Facilities Draw Warnings for GMPs
Warning Letter Roundup: Four Drug Facilities Draw Warnings for GMPs
The FDA issued warning letters to four drug manufacturing plants for failure to maintain good manufacturing practices — and to one firm for producing misbranded and unapproved drug products.